Measurements of drug-protein binding by using immobilized human serum albumin liquid chromatography-mass spectrometry
被引:50
作者:
Cheng, Y
论文数: 0引用数: 0
h-index: 0
机构:
Berlex Biosci, Richmond, CA 94806 USABerlex Biosci, Richmond, CA 94806 USA
Cheng, Y
[1
]
Ho, E
论文数: 0引用数: 0
h-index: 0
机构:
Berlex Biosci, Richmond, CA 94806 USABerlex Biosci, Richmond, CA 94806 USA
Ho, E
[1
]
Subramanyam, B
论文数: 0引用数: 0
h-index: 0
机构:
Berlex Biosci, Richmond, CA 94806 USABerlex Biosci, Richmond, CA 94806 USA
Subramanyam, B
[1
]
Tseng, HL
论文数: 0引用数: 0
h-index: 0
机构:
Berlex Biosci, Richmond, CA 94806 USABerlex Biosci, Richmond, CA 94806 USA
Tseng, HL
[1
]
机构:
[1] Berlex Biosci, Richmond, CA 94806 USA
来源:
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
|
2004年
/
809卷
/
01期
关键词:
drug-protein binding;
human serum albumin;
D O I:
10.1016/j.jchromb.2004.06.006
中图分类号:
Q5 [生物化学];
学科分类号:
071010 ;
081704 ;
摘要:
An HPLC/MS based method was used for fast and convenient determination of drug plasma-protein interactions in early drug discovery screening by employing a human serum albumin affinity column. Results from this methodology were compared with data from ultrafiltration or dialysis methods, and good agreement was observed. A compound not suitable for ultrafiltration due to the very high non-specific binding to artificial membrane of ultrafiltration device was also successfully analyzed by this method, and the protein binding determined by this chromatography method was very similar to data obtained by dialysis technique employing biological membranes. The immobilized HSA column LC/MS method also proved to be more reproducible and precise compared to ultrafiltration method in drug protein binding measurements. (C) 2004 Elsevier B.V. All rights reserved.